CLINICAL_TRIALS
trial_result
· 2026-04-15
Clinical Trial Update: Quercetin in Coronary Artery By-pass Surgery [Phase 2]
Summary
Phase 2 clinical trial evaluating quercetin in patients undergoing coronary artery bypass surgery has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Montreal Heart Institute | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-04-15